Literature DB >> 8350120

Polyunsaturated fatty acids in peroxisomal disorders: a hypothesis and a proposal for treatment.

F Roels, S Fischer, W Kissling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8350120      PMCID： PMC1015160          DOI： 10.1136/jnnp.56.8.937

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Treatment with docosahexaenoic acid favorably modifies the fatty acid composition of erythrocytes in peroxisomal patients.

Authors:  M Martinez
Journal:  Prog Clin Biol Res       Date:  1992

Review 2.  Essential fatty acids: the importance of n-3 fatty acids in the retina and brain.

Authors:  W E Connor; M Neuringer; S Reisbick
Journal:  Nutr Rev       Date:  1992-04       Impact factor: 7.110

3.  Schizophrenic patients treated with high dose phenothiazine or thioxanthene become deficient in polyunsaturated fatty acids in their thrombocytes.

Authors:  S Fischer; W Kissling; H J Kuss
Journal:  Biochem Pharmacol       Date:  1992-07-22       Impact factor: 5.858

4.  Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids.

Authors:  D G Birch; E E Birch; D R Hoffman; R D Uauy
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-07       Impact factor: 4.799

5.  Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders.

Authors:  M Martinez
Journal:  Brain Res       Date:  1992-06-26       Impact factor: 3.252
  5 in total
  8 in total

1.  Dietary docosahexaenoic acid has little effect on peroxisomes in healthy mice.

Authors:  D De Craemer; M Pauwels; C Van den Branden
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

Review 2.  Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.

Authors:  A A Farooqui; L A Horrocks
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

3.  Peroxisomes in mice fed a diet supplemented with low doses of fish oil.

Authors:  C Van den Branden; D De Craemer; M Pauwels; J Vamecq
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

Review 4.  Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: therapeutic implications.

Authors:  M Martinez
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 5.  On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

Review 6.  Omega-3 fatty acids and the peroxisome.

Authors:  C Masters
Journal:  Mol Cell Biochem       Date:  1996-12-20       Impact factor: 3.396

7.  Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study.

Authors:  M Martinez; I Mougan; M Roig; A Ballabriga
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

8.  Generalized peroxisomal disorder in male twins: fatty acid composition of serum lipids and response to n-3 fatty acids.

Authors:  O Søvik; J E Månsson; A L Bjorke Monsen; E Jellum; R K Berge
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.